(Q38887501)

English

Efficacy and safety of amphotericin B deoxycholate versus N-methylglucamine antimoniate in pediatric visceral leishmaniasis: an open-label, randomized, and controlled pilot trial in Brazil.

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28327804%20AND%20SRC:MED&resulttype=core&format=json

13 March 2020

Efficacy and safety of amphotericin B deoxycholate versus N-methylglucamine antimoniate in pediatric visceral leishmaniasis: an open-label, randomized, and controlled pilot trial in Brazil (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28327804%20AND%20SRC:MED&resulttype=core&format=json

13 March 2020

visceral leishmaniasis

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

Maria-Cristina S Pranchevicius

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28327804%20AND%20SRC:MED&resulttype=core&format=json

13 March 2020

author name string

Myrlena Mescouto Borges

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28327804%20AND%20SRC:MED&resulttype=core&format=json

13 March 2020

Elza Ferreira Noronha

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28327804%20AND%20SRC:MED&resulttype=core&format=json

13 March 2020

Gustavo Adolfo Sierra Romero

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28327804%20AND%20SRC:MED&resulttype=core&format=json

13 March 2020

César Omar Carranza-Tamayo

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28327804%20AND%20SRC:MED&resulttype=core&format=json

13 March 2020

publication date

1 January 2017

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28327804%20AND%20SRC:MED&resulttype=core&format=json

13 March 2020

Revista da Sociedade Brasileira de Medicina Tropical

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28327804%20AND%20SRC:MED&resulttype=core&format=json

13 March 2020

50

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28327804%20AND%20SRC:MED&resulttype=core&format=json

13 March 2020

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28327804%20AND%20SRC:MED&resulttype=core&format=json

13 March 2020

67-74

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28327804%20AND%20SRC:MED&resulttype=core&format=json

13 March 2020

Treatment of paediatric visceral leishmaniasis: amphotericin B or pentavalent antimony compounds?

1 reference

https://api.crossref.org/works/10.1590%2F0037-8682-0455-2016

21 January 2018

New delivery systems for amphotericin B applied to the improvement of leishmaniasis treatment.

1 reference

https://api.crossref.org/works/10.1590%2F0037-8682-0455-2016

21 January 2018

Prevalence of Leishmania infection in adult HIV/AIDS patients treated in a tertiary-level care center in Brasilia, Federal District, Brazil.

1 reference

https://api.crossref.org/works/10.1590%2F0037-8682-0455-2016

21 January 2018

Drug policy for visceral leishmaniasis: a cost-effectiveness analysis

1 reference

https://api.crossref.org/works/10.1590%2F0037-8682-0455-2016

21 January 2018

Two doses of a lipid formulation of amphotericin B for the treatment of Mediterranean visceral leishmaniasis

1 reference

https://api.crossref.org/works/10.1590%2F0037-8682-0455-2016

21 January 2018

Treatment of visceral leishmaniasis with injectable paromomycin (aminosidine). An open-label randomized phase-II clinical study.

1 reference

https://api.crossref.org/works/10.1590%2F0037-8682-0455-2016

21 January 2018

Miltefosine in children with visceral leishmaniasis: a prospective, multicentric, cross-sectional study.

1 reference

https://api.crossref.org/works/10.1590%2F0037-8682-0455-2016

21 January 2018

Oral miltefosine for the treatment of Indian visceral leishmaniasis

1 reference

https://api.crossref.org/works/10.1590%2F0037-8682-0455-2016

21 January 2018

Comparison of nephrotoxicity associated to different lipid formulations of amphotericin B: a real-life study.

1 reference

https://api.crossref.org/works/10.1590%2F0037-8682-0455-2016

21 January 2018

Amphotericin versus sodium stibogluconate in first-line treatment of Indian kala-azar

1 reference

https://api.crossref.org/works/10.1590%2F0037-8682-0455-2016

21 January 2018

Identifiers

10.1590/0037-8682-0455-2016

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28327804%20AND%20SRC:MED&resulttype=core&format=json

13 March 2020

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28327804%20AND%20SRC:MED&resulttype=core&format=json

13 March 2020

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q38887501&oldid=1868615911"